Search results
Author(s):
Matthew J Budoff
Added:
1 month ago
ACC 2025 - Outcomes from colchicine in patients with stable coronary artery disease (CAD) shows significant plaque volume progression compared to placebo at one year.Dr Matthew Budoff (UCLA Medical Centre, Los Angeles, US) joins us onsite at ACC 2025 to discuss findings from the randomized, placebo-controlled, investigator-initiated EKSTROM trial (NCT06342609; Lundquist Institute for Biomedical…
View more
Author(s):
Michelle C Morris
,
Rolf P Kreutz
Added:
1 month ago
Author(s):
Angela McInerney
,
Seán O Hynes
,
Nieves Gonzalo
Added:
3 months ago
Author(s):
Khaled A Shams
,
Hossameldin Hussein
,
Soha Romeih
,
et al
Added:
8 months ago
Author(s):
Mahmoud Izraiq
,
Nail Alshoubaki
,
Omran A Abu-Dhaim
,
et al
Added:
5 months ago
Author(s):
Hirofumi Ohashi
,
Frédéric Bouisset
,
Dimitri Buytaert
,
et al
Added:
1 year ago
Author(s):
Nouf Alanazi
,
Alaide Chieffo
,
Added:
1 week ago
TCT Middle East 2025 — We are joined by Dr Nouf Alanazi, Dr Alaide Chieffo and Dr Nadia Sutton as they discuss key takeaways from the conference for the physiological assessment of coronary artery disease.The panel explores emerging paradigms in MINOCA and INOCA management, addressing the limitations of conventional approaches. They review current guideline recommendations for functional testing…
View more
Author(s):
Daniele Andreini
Added:
7 months ago
With focus on the 2024 ESC chronic coronary syndromes (CCS) guidelines – that highlighted significant advancements in the recommendations for fractional flow reserve computed tomography (FFRct) and coronary computed tomography angiography (CTA) – this insightful series aims to equip healthcare professionals with the latest clinical strategies and practical tools for integrating FFRct and coronary…
View more
Author(s):
Kevin Cheng
,
Jonathan M Hill
,
Ranil de Silva
Added:
10 months ago
Author(s):
Max W Maffey
,
Rodrigo Bagur
Added:
9 months ago